Vitamin B3 (Niacin, Niacinamide): The Complete Supplement Guide

Quick Reference Card

Overview

The Basics

Vitamin B3 is one of eight B vitamins and comes in two primary forms: niacin (nicotinic acid) and niacinamide (nicotinamide). While both forms ultimately serve as building blocks for the same essential molecules in your body, they behave quite differently as supplements and have distinct side effect profiles.

Your body uses vitamin B3 to produce two coenzymes, NAD and NADP, that are involved in over 400 enzymatic reactions. That makes B3 one of the most broadly active vitamins in human biology. It plays roles in energy production, DNA repair, cellular signaling, and cholesterol metabolism. Most people in developed countries get plenty of niacin from their diets, particularly from poultry, meat, fish, fortified grains, and legumes. Deficiency is rare in industrialized populations but can occur in people with certain medical conditions or very restricted diets.

Niacin has a unique history in medicine. In the early twentieth century, pellagra (severe B3 deficiency) was a major public health crisis in parts of the United States and Europe, causing skin disease, dementia, diarrhea, and death. The discovery that niacin could prevent and treat pellagra was a landmark moment in nutrition science. More recently, high-dose niacin became a prescription treatment for cholesterol management, though its role has become controversial as newer evidence shows it does not reduce heart attacks or strokes despite improving lipid numbers.

The two forms of B3 also split along different modern use cases. Nicotinic acid at high doses is primarily associated with cholesterol management and its signature flushing side effect. Niacinamide, which does not cause flushing, has gained attention for skin health benefits and is widely used in both oral supplements and topical skincare products.

The Science

Niacin (vitamin B3) is the generic descriptor for nicotinic acid (pyridine-3-carboxylic acid), nicotinamide (niacinamide, pyridine-3-carboxamide), and related derivatives including nicotinamide riboside [1][2]. All forms are water-soluble and serve as precursors to the coenzymes nicotinamide adenine dinucleotide (NAD+) and nicotinamide adenine dinucleotide phosphate (NADP+).

NAD+ is required by more than 400 enzymes, making it the most utilized vitamin-derived coenzyme in human metabolism [1]. NAD+ is primarily involved in catabolic reactions that transfer potential energy from carbohydrates, fats, and proteins to ATP, while NADP+ enables anabolic reactions including cholesterol and fatty acid synthesis and maintains cellular antioxidant function [1][2].

The body also generates NAD+ from the amino acid L-tryptophan through a multi-step hepatic pathway, with an estimated conversion efficiency of approximately 60 mg tryptophan yielding 1 mg niacin equivalent (NE). This conversion is dependent on adequate status of riboflavin (B2), pyridoxine (B6), and iron, as enzymes in this pathway require these nutrients as cofactors [1][2].

Niacin deficiency sufficient to cause pellagra has been largely eliminated in industrialized nations through dietary diversity and grain fortification. Analysis of NHANES 2015-2016 data found average daily niacin intake from food and beverages of 31.4 mg in adult men and 21.3 mg in adult women, with only approximately 1% of adults falling below the Estimated Average Requirement [1]. Approximately 21% of the U.S. population takes a dietary supplement containing niacin [1].

Chemical & Nutritional Identity

One niacin equivalent (NE) is defined as 1 mg of niacin or 60 mg of dietary tryptophan. The UL applies to both nicotinic acid and niacinamide from supplemental sources, even though niacinamide does not cause flushing. The IOM established a single UL for both forms based on the rationale that a flushing-based threshold for nicotinic acid also provides an adequate safety margin for niacinamide's different adverse effects [1].

Supplemental forms differ significantly in their properties:

• Nicotinic acid (immediate-release): Rapidly absorbed, strong flushing response, effective for lipid modification
• Nicotinic acid (sustained-release): Slower absorption, reduced flushing but increased hepatotoxicity risk
• Nicotinic acid (extended-release, e.g., Niaspan): Intermediate release rate designed to balance flushing and liver safety; considered the most tolerated prescription form [3]
• Niacinamide (nicotinamide): No flushing, no lipid-lowering effect, used for general supplementation, pellagra treatment, and skin health
• Inositol hexanicotinate: Marketed as "no-flush niacin," absorption averages approximately 30% lower than nicotinic acid or niacinamide [4]

Mechanism of Action

The Basics

Vitamin B3 works by providing your body with the raw materials to make two critical helper molecules: NAD and NADP. These molecules act like tiny shuttle buses inside your cells, picking up electrons from one chemical reaction and delivering them to another. This electron-transfer process is how your cells extract energy from the food you eat.

Think of NAD as the central hub in your body's energy grid. It connects to the breakdown of sugars, fats, and proteins, converting their stored energy into ATP, the molecule your cells actually use for power. NADP, meanwhile, focuses on the building side of things: synthesizing cholesterol, fatty acids, and maintaining your cells' defenses against oxidative damage.

Beyond energy, NAD plays roles in DNA repair and cellular signaling. The enzyme PARP-1, for example, uses NAD to detect and help fix damaged DNA. Sirtuins, a family of proteins involved in aging and stress response, also depend on NAD. This broader role of NAD in cellular maintenance is part of why the related compounds NMN and nicotinamide riboside have attracted interest in longevity research, though those are covered in their own dedicated guides.

The cholesterol-lowering effect of high-dose nicotinic acid works through a different mechanism entirely, involving a receptor called HCA2 (also known as GPR109A). When nicotinic acid binds to this receptor in fat cells and the liver, it reduces the release of fatty acids and the production of triglyceride-rich lipoproteins [3]. Niacinamide does not activate this receptor, which is why it does not lower cholesterol.

The Science

All dietary forms of vitamin B3 are ultimately converted to NAD+ through distinct biosynthetic pathways. Nicotinic acid is converted via the Preiss-Handler pathway: nicotinate phosphoribosyltransferase adds a phosphoribose group to form nicotinic acid mononucleotide (NaMN), which is then adenylated to nicotinic acid adenine dinucleotide (NaAD) and amidated to NAD+ [1][2].

Niacinamide enters through the salvage pathway, where nicotinamide phosphoribosyltransferase (NAMPT) converts it to nicotinamide mononucleotide (NMN), which is then adenylated to NAD+ [2]. Tryptophan is converted to NAD+ through the de novo kynurenine pathway, primarily in the liver, requiring multiple enzymatic steps and cofactors including B2, B6, and iron [1].

NAD+ participates in two broad categories of reactions:

Redox reactions: NAD+ accepts hydride ions (H-) during catabolic oxidation of metabolic substrates, forming NADH. This is the primary mechanism of energy extraction from glycolysis, the citric acid cycle, and beta-oxidation of fatty acids [1][2].

Non-redox NAD+-consuming reactions: Several enzyme families consume NAD+ as a substrate (not merely as a cofactor), cleaving it to release nicotinamide:

• Poly(ADP-ribose) polymerases (PARPs): PARP-1 catalyzes the transfer of ADP-ribose from NAD+ to target proteins at sites of DNA damage, facilitating DNA repair [2][5]
• Sirtuins (SIRT1-7): NAD+-dependent deacetylases that regulate gene expression, metabolic adaptation, and stress responses. SIRT1 activation is associated with caloric restriction benefits [2][5]
• CD38 and CD157: NAD+-consuming ectoenzymes involved in calcium signaling and immune function [5]

The lipid-modifying effects of pharmacologic nicotinic acid involve activation of hydroxycarboxylic acid receptor 2 (HCA2/GPR109A), a Gi-coupled receptor expressed on adipocytes, macrophages, and Langerhans cells [3]. Activation inhibits adipocyte lipolysis, reduces hepatic VLDL synthesis and secretion, decreases LDL cholesterol, increases HDL cholesterol by reducing HDL catabolism, and lowers lipoprotein(a) [1][3]. Niacinamide does not activate HCA2, explaining its lack of lipid-modifying or flushing effects [3].

The niacin flush itself is mediated through HCA2 activation on Langerhans cells in the skin, triggering prostaglandin D2 (PGD2) release, which causes cutaneous vasodilation [3]. This mechanism explains why aspirin (a cyclooxygenase inhibitor) can attenuate the flush response when taken prior to nicotinic acid [6].

Absorption & Bioavailability

The Basics

Both major forms of vitamin B3, nicotinic acid and niacinamide, are absorbed very efficiently. Even at high doses of 3 to 4 grams, the body absorbs nearly all of it. This is one area where niacin stands out compared to many other supplements where absorption can be a limiting factor.

The form does matter in a different way, though. How your body processes each form after absorption differs. Nicotinic acid undergoes extensive metabolism in the liver, and the release rate from different formulations (immediate-release versus sustained-release versus extended-release) changes how much hits the liver at once. This matters because rapid, high concentrations in the liver can trigger flushing (with immediate-release) or liver stress (more common with sustained-release forms).

Niacin from food also comes in different forms. In animal foods like poultry, beef, and fish, niacin exists primarily as NAD and NADP, which are highly bioavailable. In some plant-based foods, particularly unfortified grains, niacin is bound to complex molecules that reduce its availability to about 30% [1]. Fortified and enriched foods contain free-form niacin that is fully bioavailable.

Your body can also make niacin from tryptophan, an amino acid found in protein-rich foods. The conversion rate is roughly 60 mg of tryptophan producing 1 mg of niacin, though this varies between individuals and depends on adequate levels of B2, B6, and iron [1].

The Science

Ingested niacin is absorbed primarily in the small intestine via sodium-dependent active transport at nutritional doses and by passive diffusion at pharmacologic doses [1][2]. Dietary NAD and NADP are hydrolyzed to nicotinamide in the intestinal lumen before absorption.

Bioavailability of nicotinic acid and niacinamide from supplemental sources approaches 100% [1]. Inositol hexanicotinate, marketed as "no-flush niacin," demonstrates approximately 30% lower absorption compared to nicotinic acid or niacinamide, with variable inter-individual absorption [4].

Following absorption, nicotinic acid undergoes first-pass hepatic metabolism via two pathways: conjugation with glycine to form nicotinuric acid, and amidation to form niacinamide [2][3]. The balance between these pathways is dose-dependent and formulation-dependent, which underlies the different side effect profiles of immediate-release, sustained-release, and extended-release preparations:

• Immediate-release nicotinic acid: Rapid absorption produces high peak plasma concentrations, saturating the conjugation pathway and shifting metabolism toward the amidation pathway. This results in pronounced flushing but lower hepatotoxicity risk [3]
• Sustained-release nicotinic acid: Slower absorption maintains lower peak concentrations but prolonged hepatic exposure, favoring the conjugation pathway. Associated with higher hepatotoxicity risk, including elevated transaminases and, rarely, fulminant hepatic failure [3][7]
• Extended-release nicotinic acid (Niaspan): Designed with an intermediate release rate to balance flushing and hepatotoxicity. Peak plasma concentration is lower than immediate-release but higher than sustained-release [3]

Excess niacin beyond metabolic needs is methylated in the liver to N1-methylnicotinamide and further oxidized to N1-methyl-2-pyridone-5-carboxamide, both of which are excreted in urine [1]. These urinary metabolites serve as the most sensitive biomarker of niacin status.

Managing absorption timing across multiple supplements gets complicated fast. Some need to be taken with food, others on an empty stomach. Some compete for the same absorption pathways, others enhance each other. Doserly organizes all of this into a single schedule that accounts for the interactions between everything in your stack.

Instead of juggling mental notes about which supplements to separate and which to pair, the app handles the coordination for you. It flags timing conflicts, suggests optimal windows based on the forms you're using, and builds a daily routine that gives each supplement its best chance of being absorbed effectively. One place for all the details that are easy to forget.

Research & Clinical Evidence

The Basics

The research story of niacin is one of the most nuanced in all of nutrition science. On paper, high-dose nicotinic acid does exactly what you would want a cholesterol medication to do: it raises HDL ("good") cholesterol by 10-30%, lowers LDL ("bad") cholesterol by 10-25%, reduces triglycerides by 20-50%, and lowers lipoprotein(a) by 10-30% [1][8]. These are impressive lipid changes.

The puzzle is that despite these improvements in blood lipid numbers, the largest and most rigorous clinical trials have consistently found that niacin does not actually reduce heart attacks, strokes, or deaths when added to modern treatment regimens [8][9][10]. This gap between improving risk markers and improving actual health outcomes has made niacin one of the most debated topics in cardiovascular medicine.

For pellagra (severe B3 deficiency), there is no debate. Niacin and niacinamide are effective treatments, with the WHO recommending 300 mg/day of niacinamide in divided doses for 3 to 4 weeks [11].

Niacinamide has also shown promise in dermatology. A landmark trial published in the New England Journal of Medicine found that 500 mg of oral niacinamide twice daily reduced the rate of new non-melanoma skin cancers by 23% in high-risk patients over 12 months [12]. Topical niacinamide at 4-5% concentrations has demonstrated benefits for acne, hyperpigmentation, and skin barrier function in multiple controlled studies [13].

Community reports, particularly from user review platforms, describe notable mood and anxiety benefits from niacin supplementation, with some users reporting dramatic improvements in depression. While these reports are consistent and enthusiastic, controlled clinical trial evidence specifically supporting niacin as an antidepressant is limited, and these anecdotal accounts should be interpreted cautiously.

The Science

Cardiovascular Outcomes

The Coronary Drug Project (CDP, 1975) was the first large-scale trial to examine nicotinic acid for cardiovascular outcomes. In 8,341 men aged 30-64 with prior myocardial infarction, 3,000 mg/day nicotinic acid for a mean of 6.2 years produced a 9.9% reduction in serum total cholesterol and a 26.1% reduction in triglycerides [8]. Nonfatal myocardial infarctions were significantly reduced during the treatment period, though overall mortality was not. A notable finding emerged 9 years after the study ended: participants who had received nicotinic acid experienced 11% fewer all-cause deaths than those who had received placebo [8].

However, subsequent trials in the modern statin era have not replicated these benefits:

AIM-HIGH (2011): In 3,414 patients with established cardiovascular disease already receiving statins, addition of 1,500-2,000 mg/day extended-release niacin for 3 years did not reduce cardiovascular events despite further improving lipid profiles. The trial was stopped early for futility, and patients receiving niacin had an increased risk of ischemic stroke [9].

HPS2-THRIVE (2014): The largest niacin trial to date randomized 25,673 adults with cardiovascular disease taking statins to receive 2 g/day extended-release nicotinic acid plus laropiprant (a flushing reducer) or placebo for a median of 4 years. Despite favorable lipid changes (LDL reduction of 10 mg/dL, triglyceride reduction of 33 mg/dL, HDL increase of 6 mg/dL), there was no significant reduction in major vascular events. The nicotinic acid group had significantly higher rates of new-onset diabetes, gastrointestinal complications, bleeding events, and skin reactions [10].

A 2017 Cochrane systematic review examining 23 RCTs (n=39,195) concluded that nicotinic acid therapy provided no significant reduction in overall mortality, cardiovascular mortality, or rates of myocardial infarction or stroke, while 18% of participants discontinued treatment due to side effects [14].

Dermatological Evidence (Niacinamide)

The ONTRAC trial (2015) randomized 386 immunocompetent patients with a history of at least two non-melanoma skin cancers to receive 500 mg oral niacinamide twice daily or placebo for 12 months. The niacinamide group had a 23% lower rate of new non-melanoma skin cancers (P = 0.02) and a 13% lower rate of new actinic keratoses (P < 0.001) [12].

For acne vulgaris, a double-blind trial comparing 4% topical niacinamide gel to 1% clindamycin gel found comparable efficacy in reducing inflammatory lesion counts at 8 weeks [13]. Niacinamide has also demonstrated efficacy in reducing hyperpigmentation, improving skin barrier function through increased ceramide synthesis, and reducing transepidermal water loss in controlled studies [13].

Evidence & Effectiveness Matrix

Benefits & Potential Effects

The Basics

The benefits of vitamin B3 depend heavily on which form you are using and at what dose.

At nutritional doses (14-16 mg/day from diet or standard supplements), vitamin B3 supports fundamental biological processes: energy metabolism, DNA repair, and cellular signaling. For most healthy people eating a varied diet, these needs are already met without supplementation.

At higher supplemental doses, the two forms diverge in their benefit profiles:

Niacinamide (nicotinamide) at doses of 250-500 mg/day has the strongest evidence for skin health benefits. It supports the skin barrier, may reduce the risk of certain skin cancers in high-risk individuals, and has anti-inflammatory properties that benefit conditions like acne. It is well-tolerated and does not cause flushing.

Nicotinic acid (niacin) at pharmacologic doses (500-2,000 mg/day) can substantially improve cholesterol and triglyceride levels, though current evidence indicates this does not translate into reduced cardiovascular events for most people. Some users report notable mood and anxiety benefits at moderate to high doses, though these reports lack robust clinical trial support.

Both forms effectively treat and prevent pellagra (B3 deficiency), with niacinamide generally preferred because it is better tolerated [11].

The Science

Lipid modification (nicotinic acid only): Pharmacologic doses of nicotinic acid (1-3 g/day) produce consistent effects on the lipid profile: HDL cholesterol increases of 10-30%, LDL cholesterol reductions of 10-25%, triglyceride reductions of 20-50%, and lipoprotein(a) reductions of 10-30% [1][3]. These effects are mediated through HCA2 receptor activation and subsequent changes in hepatic lipoprotein metabolism. Despite these favorable lipid changes, major RCTs have not demonstrated reduction in cardiovascular events when niacin is added to statin therapy [9][10][14].

Skin cancer chemoprevention (niacinamide): Oral niacinamide 500 mg twice daily for 12 months reduced the rate of new non-melanoma skin cancers by 23% and actinic keratoses by 13% in a phase III RCT of high-risk patients [12]. The proposed mechanism involves enhancement of cellular energy for DNA repair through increased NAD+ availability, improving the repair of ultraviolet radiation-induced DNA damage [12].

Dermatological benefits (niacinamide): Topical niacinamide (2-5%) has demonstrated efficacy in controlled trials for reducing sebum production, decreasing inflammatory acne lesions, improving skin hyperpigmentation, enhancing ceramide synthesis and skin barrier function, and reducing transepidermal water loss [13].

Pellagra treatment: Both nicotinic acid and niacinamide effectively treat pellagra. The WHO recommends niacinamide 300 mg/day in divided doses for 3-4 weeks, as niacinamide avoids the flushing side effect of nicotinic acid [11].

NAD+ repletion: All forms of vitamin B3 ultimately serve as NAD+ precursors. Maintaining adequate NAD+ levels supports PARP-mediated DNA repair, sirtuin-dependent gene regulation, and mitochondrial function [2][5]. The clinical significance of NAD+ repletion from standard-dose B3 supplementation in non-deficient individuals remains an active area of investigation.

Side Effects & Safety

The Basics

The side effect profile of vitamin B3 depends almost entirely on which form and what dose you are taking.

The niacin flush is the most distinctive and widely discussed side effect. When you take nicotinic acid (not niacinamide), doses of 30-50 mg or more can trigger a flushing reaction: your face, arms, and chest turn red, and you feel warmth, tingling, and itching. This happens because nicotinic acid triggers the release of prostaglandin D2 in your skin, causing blood vessels to dilate. The flush typically begins 15-30 minutes after taking niacin and lasts 30-60 minutes. It is not dangerous, but it can be intensely uncomfortable, and it is the primary reason many people stop taking niacin.

Strategies that may reduce flushing include taking niacin with food, starting at a low dose and gradually increasing, taking aspirin or ibuprofen 30 minutes beforehand, and avoiding alcohol, hot beverages, and spicy foods around the time of dosing. With consistent use, most people develop tolerance to the flushing response over days to weeks.

Niacinamide does not cause flushing because it does not activate the same receptor. It is generally well-tolerated at doses up to 1,000-1,500 mg/day. At very high doses (3,000 mg/day or above), nausea, vomiting, and liver toxicity have been reported [1].

At pharmacologic doses (1,000-3,000 mg/day), nicotinic acid carries more serious risks: liver damage (particularly with sustained-release formulations), worsening of blood sugar control, increased uric acid levels potentially triggering gout, gastrointestinal symptoms (nausea, heartburn, abdominal pain), and, rarely, vision changes [1][3][7].

No adverse effects have been reported from the amounts of niacin naturally present in foods [1].

The Science

Flushing (nicotinic acid): Cutaneous flushing occurs in most individuals at doses of 30-50 mg or above of immediate-release nicotinic acid. The mechanism involves activation of HCA2 (GPR109A) on epidermal Langerhans cells, stimulating cyclooxygenase-mediated prostaglandin D2 (PGD2) production, which acts on DP1 receptors on dermal vascular smooth muscle to produce vasodilation [3][6]. Pre-treatment with aspirin (325 mg) or ibuprofen (200 mg) 30 minutes prior to nicotinic acid dosing reduces flushing severity by inhibiting prostaglandin synthesis [6]. Tolerance develops with repeated dosing as prostaglandin-mediated pathways desensitize.

Hepatotoxicity: Risk varies by formulation. Sustained-release nicotinic acid carries the highest hepatotoxicity risk, with cases of fulminant hepatic failure reported [3][7]. This is attributed to prolonged hepatic exposure favoring the conjugation metabolic pathway. Extended-release nicotinic acid (Niaspan) has a lower but non-zero hepatotoxicity risk. The American College of Cardiology and American Heart Association recommend monitoring hepatic transaminases before initiating niacin therapy, during dose escalation, and every 6 months thereafter [15]. Therapy should be discontinued if transaminase levels exceed 2-3 times the upper limit of normal [15].

Metabolic effects: High-dose nicotinic acid (1,500 mg/day or more) can impair glucose tolerance and worsen insulin resistance through increased hepatic glucose production [1][7]. In the HPS2-THRIVE trial, participants randomized to nicotinic acid had significantly higher rates of new-onset diabetes [10]. Nicotinic acid also increases serum uric acid levels, potentially precipitating gout in susceptible individuals [6].

Nicotinamide toxicity: Niacinamide carries a different toxicity profile. Nausea, vomiting, and hepatotoxicity have been reported at doses of 3,000 mg/day and above [1]. In studies of hemodialysis patients, niacinamide at 500-1,500 mg/day was associated with diarrhea and thrombocytopenia [1][16].

UL context: The IOM established a UL of 35 mg/day for supplemental niacin in adults, based on the flushing threshold. This UL explicitly does not apply to individuals taking niacin under medical supervision for therapeutic purposes [1].

Managing side effect risks across a multi-supplement stack can feel overwhelming, especially when interactions between supplements, medications, and foods add layers of complexity. Doserly brings all of that into a single safety view so nothing falls through the cracks.

Rather than researching every possible interaction yourself, the app checks your full stack automatically and flags supplement-drug and supplement-supplement interactions that warrant attention. If you do experience something unexpected, logging it takes seconds, and over time the app helps you spot patterns: whether symptoms correlate with specific doses, timing, or combinations. One place for the safety picture that matters most when your stack grows beyond a few bottles.

Dosing & Usage Protocols

The Basics

Niacin dosing varies enormously depending on the goal, and getting the form and dose matched correctly is critical because the safety profile shifts dramatically at higher doses.

For general nutritional support, the RDA of 14-16 mg NE per day is easily met through diet for most people. Standard multivitamins and B-complex supplements typically provide 20-50 mg, which is above the RDA but well within safe limits.

For skin health benefits with niacinamide, the most commonly studied dose is 500 mg once or twice daily. This is the dose used in the ONTRAC skin cancer prevention trial [12].

For cholesterol management, nicotinic acid doses of 500-2,000 mg/day have been studied, with effects on lipid profiles generally dose-dependent. This is prescription territory and requires medical supervision due to the risk of liver toxicity, blood sugar disruption, and other adverse effects.

The UL of 35 mg/day from supplements applies to self-directed supplementation and is based on the flushing threshold. Doses above this level are best used only under medical guidance.

The Science

Established reference intakes (IOM 1998):

Therapeutic dosing (nicotinic acid for dyslipidemias):

Extended-release nicotinic acid (prescription): Initial dose 500 mg at bedtime with a low-fat snack, titrated over 4-8 weeks to a maintenance dose of 1,000-2,000 mg/day [15]. Immediate-release nicotinic acid: 100 mg three times daily, titrated to 1,500-3,000 mg/day in divided doses [15]. Both protocols require gradual titration to minimize flushing and hepatotoxicity risk.

Niacinamide dosing:

Pellagra treatment: 300 mg/day in divided doses for 3-4 weeks (WHO recommendation) [11]. Skin cancer chemoprevention: 500 mg twice daily [12]. General supplementation: 100-500 mg/day is commonly available in over-the-counter supplements.

Monitoring requirements at therapeutic doses: The ACC/AHA recommend measuring hepatic transaminases, fasting blood glucose or HbA1c, and uric acid before initiating therapy, during dose escalation, and every 6 months thereafter [15].

When your stack includes several supplements, each with its own dose, form, and timing requirements, the logistics alone can derail consistency. Doserly consolidates all of it into one protocol view, so every dose across your entire routine is accounted for without spreadsheets or guesswork.

The app also tracks cumulative intake for nutrients that appear in multiple products. If your multivitamin, standalone supplement, and fortified protein shake all contain the same nutrient, Doserly adds them up and shows you the total alongside recommended and upper limits. Managing a thoughtful supplement protocol shouldn't require a degree in nutrition science. The app handles the complexity so you can focus on staying consistent.

What to Expect (Timeline)

Weeks 1-2: With nicotinic acid, the most immediate experience is flushing, which typically occurs within the first few doses and is most intense initially. Flushing severity generally diminishes with consistent daily use as the body develops tolerance. With niacinamide, no flushing occurs, and most users do not notice immediate effects at standard supplement doses.

Weeks 2-4: If taking nicotinic acid for lipid management, initial changes in cholesterol and triglyceride levels may be detectable on blood work within 2-4 weeks, though most studies report meaningful lipid changes at 4-8 weeks. Flushing tolerance should be well-established by this point for most users.

Weeks 4-8: Mood and anxiety benefits reported by community users, where they occur, typically become apparent in this window. Lipid panels should show clearer trends. Users taking niacinamide for skin health may begin noticing early improvements in acne, oiliness, and skin texture, though dermatological benefits often take longer to fully manifest.

Weeks 8-12+: For skin cancer chemoprevention with niacinamide, the ONTRAC trial assessed outcomes at 12 months, and benefits were observed over the full treatment period [12]. For lipid management, stable maintenance doses are typically established and maintained long-term with regular monitoring. Community reports suggest that mood benefits, if they occur, tend to be sustained with continued use.

Upon discontinuation: Lipid-modifying effects of nicotinic acid reverse upon stopping the supplement. The ONTRAC trial noted that skin cancer protection with niacinamide also diminished after discontinuation, suggesting ongoing supplementation is needed for continued benefit [12].

Interactions & Compatibility

SYNERGISTIC

• Aspirin (not a supplement per se, but relevant): Pre-dosing with aspirin (325 mg) or ibuprofen (200 mg) 30 minutes before nicotinic acid reduces flushing severity by inhibiting prostaglandin D2 synthesis [6]
• Vitamin B1 (Thiamine): Part of the B-complex family. B vitamins work synergistically in energy metabolism. Often taken together in B-complex formulations
• Vitamin B2 (Riboflavin): Required cofactor for the enzymatic conversion of tryptophan to niacin. Adequate B2 status supports endogenous niacin production [1]
• Vitamin B6: Another required cofactor for tryptophan-to-niacin conversion. Deficiency in B6 can impair niacin synthesis from dietary protein [1]
• Iron: Required for enzymes in the tryptophan-to-niacin conversion pathway [1]
• B-Complex: Niacin is commonly included in B-complex supplements. The B vitamins share metabolic pathways and are often recommended together

CAUTION / AVOID

• Statin medications (lovastatin, simvastatin, atorvastatin, etc.): Adding niacin to statin therapy provides minimal additional cardiovascular benefit while increasing the risk of side effects, including a rare but serious risk of rhabdomyolysis, particularly with simvastatin [9][10]. Medical supervision required
• Antidiabetes medications: Nicotinic acid at doses of 1,500 mg/day or above can increase blood glucose levels and impair insulin sensitivity. Patients on diabetes medications may require dose adjustments [1][7]
• Isoniazid and pyrazinamide (tuberculosis medications): These drugs are structural analogs of niacin and interfere with tryptophan-to-niacin conversion and niacin-to-NAD conversion, potentially causing deficiency [1]
• Bile acid sequestrants (cholestyramine, colestipol, colesevelam): Should be taken at least 4-6 hours apart from niacin to avoid reduced absorption [6]
• Anticoagulant/antiplatelet agents: Niacin may add to bleeding risk. Use with caution [6]
• Zinc: May worsen niacin side effects, particularly flushing and itching [6]
• Chromium: Taking niacin with chromium may lower blood sugar, requiring monitoring in people with diabetes [6]
• Alcohol: Increases risk of liver damage and worsens flushing and itching [6][7]
• Hepatotoxic substances: Niacin should not be combined with other substances known to cause liver damage [6]

How to Take / Administration Guide

Recommended forms: For general supplementation and skin health, niacinamide (nicotinamide) is the preferred form because it does not cause flushing and is well-tolerated. For lipid management, nicotinic acid is the form with documented effects on cholesterol and triglycerides, available as immediate-release, sustained-release, and extended-release formulations. Extended-release nicotinic acid is generally regarded as the most tolerated prescription formulation.

Timing: Extended-release niacin (Niaspan) is typically taken at bedtime with a low-fat snack. Immediate-release nicotinic acid is usually divided into 2-3 doses per day with meals. Niacinamide can be taken at any time of day, with or without food.

Flushing management strategies:

• Start at a low dose (50-100 mg) and increase gradually over weeks
• Take with food to slow absorption and reduce peak plasma levels
• Consider taking aspirin (325 mg) or ibuprofen (200 mg) 30 minutes before niacin
• Avoid alcohol, hot beverages, and spicy foods around the time of dosing
• Expect flushing to diminish with consistent daily use as tolerance develops

Form considerations:

• Swallow extended-release tablets whole; do not crush, chew, or break (this destroys the controlled release mechanism and delivers the full dose at once)
• If switching between niacin brands or formulations, consult a healthcare provider as dose adjustments may be needed
• "No-flush" niacin (inositol hexanicotinate) avoids flushing but has approximately 30% lower absorption and may not provide the same lipid-modifying effects [4]

Cycling: Niacin does not typically require cycling. For lipid management, it is used as a continuous, long-term therapy. For general supplementation with niacinamide, continuous use is the standard approach.

Choosing a Quality Product

Third-party certifications: Look for products verified by USP, NSF International, ConsumerLab, or Informed Sport. These certifications confirm the product contains what the label claims and is free from harmful contaminants.

Form selection:

• For general wellness and skin: niacinamide (nicotinamide) is preferred. Look for "niacinamide" or "nicotinamide" on the label.
• For cholesterol management: nicotinic acid, ideally as a prescription extended-release formulation under medical supervision
• Avoid products labeled "no-flush niacin" if the goal is lipid modification, as these typically contain inositol hexanicotinate, which has lower absorption and may not provide lipid benefits [4]

Dose transparency: Quality products clearly state the amount of niacin per serving on the label. Avoid proprietary blends that hide individual ingredient amounts.

Red flags:

• Products claiming to lower cholesterol without specifying the form as nicotinic acid
• Extremely high doses (above 500 mg) sold as general supplements without appropriate safety warnings
• "No-flush niacin" marketed with cholesterol-lowering claims
• Sustained-release formulations sold over-the-counter at high doses without liver safety warnings

Purity considerations: Standard B3 supplements are generally straightforward compounds with low contamination risk. However, third-party testing for heavy metals and purity is still advisable, particularly for products sourced internationally.

Storage & Handling

Vitamin B3 supplements (both nicotinic acid and niacinamide) should be stored at room temperature in a tightly closed container, away from heat, moisture, and direct light. No refrigeration is required. These are relatively stable compounds that do not degrade rapidly under normal storage conditions.

Extended-release tablets should be kept in their original packaging to protect the controlled-release coating. Do not transfer to pill organizers that expose them to moisture for extended periods.

Standard shelf life for B3 supplements is typically 2-3 years from the date of manufacture when stored properly. Check the expiration date on the product label.

Lifestyle & Supporting Factors

Dietary sources: Niacin is abundant in many common foods. Poultry, beef, fish, pork, and organ meats provide 5-10 mg per serving in the highly bioavailable forms NAD and NADP. Peanuts, legumes, and enriched grains are also good sources. A typical American diet provides well above the RDA without supplementation [1].

Tryptophan conversion: The body can synthesize niacin from the amino acid tryptophan, found in protein-rich foods. Turkey, chicken, eggs, and dairy products are good sources. This conversion requires adequate B2, B6, and iron status [1].

Populations at higher risk of deficiency:

• People with alcohol use disorders (alcohol impairs niacin absorption and metabolism)
• People with very restricted diets or malnutrition
• People with Hartnup disease (rare genetic disorder affecting tryptophan transport)
• People with carcinoid syndrome (tryptophan is preferentially converted to serotonin instead of niacin)
• People taking isoniazid or pyrazinamide for tuberculosis
• People with inadequate riboflavin, pyridoxine, or iron intake

Signs that may suggest low niacin status: Fatigue, poor appetite, inflamed skin (particularly symmetrical lesions on sun-exposed areas), digestive problems, depression, and confusion. Severe deficiency (pellagra) is characterized by the "4 D's": dermatitis, diarrhea, dementia, and death [1][11].

Lab monitoring: Blood niacin levels are not reliable indicators of status. Urinary excretion of niacin metabolites (N1-methyl-nicotinamide and N1-methyl-2-pyridone-5-carboxamide) is the most sensitive measure. A niacin number (NAD-to-NADP ratio in whole blood, multiplied by 100) below 130 suggests deficiency [1].

Regulatory Status & Standards

United States (FDA): Niacin (nicotinic acid and niacinamide) is classified as a dietary supplement under DSHEA and is widely available over-the-counter at nutritional doses. Extended-release nicotinic acid (Niaspan) is also available as an FDA-approved prescription drug for treatment of dyslipidemias, specifically for raising HDL cholesterol and lowering triglycerides. Note that FDA ruled in November 2022 that nicotinamide mononucleotide (NMN) may not be legally marketed as a dietary supplement due to its authorization for investigation as a new drug [1].

Canada (Health Canada): Niacin is available as a Natural Health Product (NHP) with a Natural Product Number (NPN). Monograph compliance required for specific health claims.

European Union (EFSA): Niacin is an authorized nutrient for use in food supplements. EFSA has established authorized health claims for niacin's contribution to normal energy metabolism, normal nervous system function, normal psychological function, and maintenance of normal skin and mucous membranes.

Australia (TGA): Listed as a complementary medicine ingredient. Available over-the-counter in permitted forms and doses.

Athlete & Sports Regulatory Status:

• WADA: Niacin (vitamin B3) is NOT on the World Anti-Doping Agency Prohibited List. It is permitted at all times, both in-competition and out-of-competition.
• National Anti-Doping Agencies: No major national anti-doping organizations (USADA, UKAD, Sport Integrity Canada, Sport Integrity Australia, NADA Germany) have issued alerts or restrictions regarding standard vitamin B3 supplements.
• Professional Sports Leagues: Niacin is not prohibited by any major professional sports league (NFL, NBA, MLB, NHL, MLS, NCAA).
• NCAA: Niacin is not on the NCAA banned substance list. However, NCAA athletic departments are encouraged to provide supplements that carry NSF Certified for Sport or Informed Sport certification to ensure purity.
• Athlete Certification Programs: Niacin products certified by Informed Sport, NSF Certified for Sport, and the Cologne List are available. Athletes should seek these certifications to minimize contamination risk.
• GlobalDRO: Athletes can verify the current status of niacin products at GlobalDRO.com.

Regulatory status and prohibited substance classifications change frequently. Athletes should always verify the current status of any supplement with their sport's governing body, their national anti-doping agency, and a qualified sports medicine professional before use. Third-party certification (Informed Sport, NSF Certified for Sport) reduces but does not eliminate the risk of contamination with prohibited substances.

Frequently Asked Questions

What is the difference between niacin and niacinamide?
Niacin (nicotinic acid) and niacinamide (nicotinamide) are both forms of vitamin B3 and both serve as NAD+ precursors in the body. The key differences are that nicotinic acid causes flushing and can modify cholesterol levels at high doses, while niacinamide does not cause flushing and does not affect cholesterol. For general supplementation and skin health, niacinamide is the more commonly recommended form.

Is the niacin flush dangerous?
The niacin flush (redness, warmth, tingling, itching of the skin) caused by nicotinic acid is generally not dangerous. It is a prostaglandin-mediated vasodilation response that subsides within 30-60 minutes. However, it can be intensely uncomfortable, and in rare cases, severe reactions including hives and significant blood pressure drops have been reported. Most people develop tolerance with continued daily use.

Can niacin help with depression or anxiety?
User reports from community platforms describe notable improvements in mood and anxiety with niacin supplementation, with some describing dramatic relief from depression. However, there is limited controlled clinical trial evidence specifically supporting niacin as a treatment for these conditions. These anecdotal reports should be considered alongside, not in place of, evidence-based depression treatments. Anyone experiencing depression or anxiety should consult a healthcare professional.

Should I take niacin for cholesterol?
Based on current evidence, the American College of Cardiology and American Heart Association position is that niacin therapy is not recommended as first-line treatment for high cholesterol. Statin medications are preferred. Niacin may be considered for individuals who cannot tolerate statins or who have specific lipid profile challenges, but only under medical supervision due to side effect risks [15].

What dose of niacinamide is good for skin?
The most commonly studied dose for skin health benefits is 500 mg taken once or twice daily, which is the protocol used in the landmark ONTRAC trial for skin cancer prevention [12]. For topical use, concentrations of 2-5% niacinamide are standard in dermatological studies.

Can I switch from nicotinic acid to niacinamide to avoid flushing?
Switching eliminates flushing entirely, since niacinamide does not activate the HCA2 receptor that causes the flush response. However, niacinamide does not provide the same lipid-modifying (cholesterol-lowering) effects as nicotinic acid. If the primary goal was cholesterol management, switching to niacinamide would remove that benefit.

Is "no-flush niacin" actually effective?
Products labeled "no-flush niacin" typically contain inositol hexanicotinate rather than nicotinic acid. While inositol hexanicotinate is indeed flush-free, its absorption is approximately 30% lower than nicotinic acid, and available evidence does not support the same lipid-modifying effects [4]. For cholesterol management, it should not be considered equivalent to nicotinic acid.

How much niacin can I get from food?
A typical serving of chicken breast (3 oz) provides about 10 mg of niacin, similar to turkey breast. Beef liver is one of the richest sources at nearly 15 mg per serving. Peanuts, enriched grains, salmon, and tuna are also good sources. Most adults in the United States consume 21-31 mg/day from food alone, well above the RDA of 14-16 mg [1].

Can I take niacin during pregnancy?
Niacin for preventing or treating deficiency is considered likely safe during pregnancy and lactation when used at appropriate doses. However, prescription high-dose niacin for cholesterol management should not be used during pregnancy [6].

Does niacin help with sleep?
Some community reports suggest improved sleep quality with niacin, particularly when taken before bed. However, there is no significant clinical trial evidence specifically demonstrating niacin as a sleep aid. Any sleep benefits may be secondary to mood improvement or the calming effect that follows the flushing response.

Myth vs. Fact

Myth: Niacin is a safe, natural alternative to statin medications for lowering cholesterol.
Fact: While nicotinic acid does improve cholesterol and triglyceride numbers, the largest clinical trials (AIM-HIGH, HPS2-THRIVE) have shown that niacin does not reduce heart attacks, strokes, or deaths when added to statin therapy. The American College of Cardiology and American Heart Association do not recommend niacin as a first-line alternative to statins [9][10][14][15].

Myth: All forms of vitamin B3 are interchangeable.
Fact: Nicotinic acid and niacinamide have fundamentally different pharmacological properties despite both being NAD+ precursors. Nicotinic acid causes flushing and modifies cholesterol; niacinamide does neither. Inositol hexanicotinate has lower absorption than both. "No-flush niacin" is not equivalent to nicotinic acid for lipid management [4].

Myth: The niacin flush means you are allergic to niacin.
Fact: The flushing response is a normal pharmacological effect caused by prostaglandin D2 release, not an allergic reaction. While the warmth, redness, and tingling can feel alarming, they are expected responses to nicotinic acid and typically diminish with continued use [3][6]. True allergic reactions to niacin (anaphylaxis) are extremely rare.

Myth: Niacin at any dose is a proven treatment for depression.
Fact: While community reports of mood improvement with niacin are notably consistent and enthusiastic, controlled clinical trial evidence specifically supporting niacin as an antidepressant is limited. The anecdotal reports are promising but should not be substituted for evidence-based depression treatment. Anyone experiencing depression should work with a healthcare professional.

Myth: You need to supplement with niacin because most people are deficient.
Fact: The opposite is true for most people in developed countries. NHANES data shows that only about 1% of U.S. adults have niacin intakes below the Estimated Average Requirement. The average adult intake from food alone is 21-31 mg/day, well above the RDA of 14-16 mg [1]. Deficiency (pellagra) is largely a disease of extreme poverty, very restricted diets, or specific medical conditions.

Myth: Sustained-release niacin is safer than immediate-release because it reduces flushing.
Fact: While sustained-release niacin does reduce flushing, it is actually associated with a higher risk of hepatotoxicity (liver damage) compared to immediate-release formulations. The extended-release prescription form (Niaspan) was designed to balance both concerns with an intermediate release rate [3][7].

Myth: High-dose niacin boosts NAD+ levels better than any other supplement.
Fact: While all forms of B3 are NAD+ precursors, specialized NAD+ precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) have been specifically studied for their ability to raise NAD+ levels. The comparative efficacy of different NAD+ precursors at raising tissue NAD+ levels in humans remains an active area of research, and standard niacin at nutritional doses primarily addresses basic metabolic needs rather than supraphysiologic NAD+ enhancement [2][5].

Sources & References

Government/Institutional Sources

[1] National Institutes of Health, Office of Dietary Supplements. "Niacin: Fact Sheet for Health Professionals." Updated November 18, 2022. https://ods.od.nih.gov/factsheets/Niacin-HealthProfessional/

[2] Institute of Medicine, Food and Nutrition Board. "Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline." Washington, DC: National Academy Press, 1998. https://nap.nationalacademies.org/catalog/6015

Systematic Reviews & Meta-Analyses

[3] Garg A, Sharma A, Krishnamoorthy P, et al. "Role of niacin in current clinical practice: A systematic review." The American Journal of Medicine. 2017;130:173-87. https://pubmed.ncbi.nlm.nih.gov/27506907/

[14] Schandelmaier S, Briel M, Saccilotto R, et al. "Niacin for primary and secondary prevention of cardiovascular events." Cochrane Database of Systematic Reviews. 2017;6:CD009744. https://pubmed.ncbi.nlm.nih.gov/28616955/

Clinical Trials & RCTs

[8] The Coronary Drug Project Research Group. "Clofibrate and niacin in coronary heart disease." JAMA. 1975;231:360-81. https://pubmed.ncbi.nlm.nih.gov/1088963/

[9] The AIM-HIGH Investigators. "Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy." N Engl J Med. 2011;365:2255-67. https://pubmed.ncbi.nlm.nih.gov/22085343/

[10] HPS2-THRIVE Collaborative Group. "Effects of extended-release niacin with laropiprant in high-risk patients." N Engl J Med. 2014;371:203-12. https://pubmed.ncbi.nlm.nih.gov/25014686/

[12] Chen AC, Martin AJ, Choy B, et al. "A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention." N Engl J Med. 2015;373:1618-26. https://pubmed.ncbi.nlm.nih.gov/26488693/

[13] Shalita AR, Smith JG, Parish LC, et al. "Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris." Int J Dermatol. 1995;34:434-7. https://pubmed.ncbi.nlm.nih.gov/7657446/

[16] Takahashi Y, Tanaka A, Nakamura T, et al. "Nicotinamide suppresses hyperphosphatemia in hemodialysis patients." Kidney International. 2004;65:1099-1104. https://pubmed.ncbi.nlm.nih.gov/14871430/

Observational Studies & Reviews

[4] Keenan JM. "Wax-matrix extended-release niacin vs inositol hexanicotinate: a comparison in persons with mild to moderate dyslipidemia." J Clin Lipidol. 2013;7:14-23. https://pubmed.ncbi.nlm.nih.gov/23351578/

[5] Kirkland JB. "Niacin." In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, eds. Modern Nutrition in Health and Disease, 11th ed. Baltimore, MD: Williams & Wilkins; 2014:331-40.

[6] Mayo Clinic. "Niacin." Updated March 21, 2025. https://www.mayoclinic.org/drugs-supplements-niacin/art-20364984

[7] McKenney JM, Proctor JD, Harris S, Chinchili VM. "A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients." JAMA. 1994;271:672-7. https://pubmed.ncbi.nlm.nih.gov/8309029/

[11] World Health Organization. "Pellagra and its prevention and control in major emergencies." 2000. https://www.who.int/nutrition/publications/emergencies/pellagra_prevention_control/en/

[15] Grundy SM, Stone NJ, Bailey AL, et al. "2018 AHA/ACC Guideline on the management of blood cholesterol." Circulation. 2019;73:3234-3237. https://pubmed.ncbi.nlm.nih.gov/30423391/

Related Supplement Guides

Same Category (B Vitamins)

• Vitamin B1 (Thiamine, Benfotiamine)
• Vitamin B2 (Riboflavin)
• Vitamin B5 (Pantothenic Acid)
• Vitamin B6
• Vitamin B7 (Biotin)
• Vitamin B9 (Folic Acid, Methylfolate)
• Vitamin B12
• B-Complex
• Choline

Related NAD+ Precursors

• NMN (Nicotinamide Mononucleotide)
• NR (Nicotinamide Riboside)

Common Interactions

• Iron
• Zinc
• Chromium
• Magnesium

Related Health Goal

• Vitamin C (skin health, antioxidant)
• Vitamin E (antioxidant, cardiovascular)
• Selenium (skin health, antioxidant)